Gerhard v. Saul

CourtDistrict Court, N.D. California
DecidedMarch 12, 2020
Docket1:18-cv-07516
StatusUnknown

This text of Gerhard v. Saul (Gerhard v. Saul) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gerhard v. Saul, (N.D. Cal. 2020).

Opinion

1 UNITED STATES DISTRICT COURT 2 NORTHERN DISTRICT OF CALIFORNIA 3 EUREKA DIVISION 4 5 CHRISTINA L GERHARD, Case No. 18-cv-07516-RMI

6 Plaintiff, ORDER RE: MOTIONS FOR 7 v. SUMMARY JUDGMENT

8 ANDREW SAUL, Re: Dkt. Nos. 14, 15 9 Defendant.

10 11 Plaintiff seeks judicial review of an administrative law judge (“ALJ”) decision denying her 12 application for disability insurance benefits and supplemental security income under Titles II and 13 XVI of the Social Security Act, respectively. Plaintiff’s request for review of the ALJ’s 14 unfavorable decision was denied by the Appeals Council, thus, the ALJ’s decision is the “final 15 decision” of the Commissioner of Social Security which this court may review. See 42 U.S.C. §§ 16 405(g), 1383(c)(3). Both parties have consented to the jurisdiction of a magistrate judge (dkts. 6 & 17 11), and both parties have moved for summary judgment (dkts. 14 & 15). For the reasons stated 18 below, the court will grant Plaintiff’s motion for summary judgment and deny Defendant’s motion 19 for summary judgment. 20 LEGAL STANDARDS 21 The Commissioner’s findings “as to any fact, if supported by substantial evidence, shall be 22 conclusive.” 42 U.S.C. § 405(g). A district court has a limited scope of review and can only set 23 aside a denial of benefits if it is not supported by substantial evidence or if it is based on legal 24 error. Flaten v. Sec’y of Health & Human Servs., 44 F.3d 1453, 1457 (9th Cir. 1995). Substantial 25 evidence is “such relevant evidence as a reasonable mind might accept as adequate to support a 26 conclusion.” Biestek v. Berryhill, 139 S. Ct. 1148, 1154 (2019); Sandgathe v. Chater, 108 F.3d 27 978, 979 (9th Cir. 1997). “In determining whether the Commissioner’s findings are supported by 1 considering “both the evidence that supports and the evidence that detracts from the 2 Commissioner’s conclusion.” Reddick v. Chater, 157 F.3d 715, 720 (9th Cir. 1998). The 3 Commissioner’s conclusion is upheld where evidence is susceptible to more than one rational 4 interpretation. Burch v. Barnhart, 400 F.3d 676, 679 (9th Cir. 2005). 5 PROCEDURAL HISTORY 6 On February 16, 2017, Plaintiff filed an application for disability insurance benefits and 7 supplemental security income under Titles II and XVI of the Social Security Act, alleging an onset 8 date of February 11, 2016. See Administrative Record1 (“AR”) at 10. The ALJ denied the 9 application on July 13, 2018. Id. at 18. The Appeals Council denied Plaintiff’s request for review 10 on October 15, 2018. Id. at 1-3. 11 SUMMARY OF THE RELEVANT EVIDENCE 12 Plaintiff’s application for Titles II and XVI benefits alleged disability due to: bone marrow 13 cancer, depression, anxiety, diarrhea, anemia, chronic and constant bone pain, gout, and lack of 14 concentration. AR at 243. The ALJ found that Plaintiff’s myelofibrosis condition was severe. Id. at 15 12. In this court, Plaintiff assigns error to the ALJ’s rejection of Plaintiff’s testimony regarding 16 pain, symptoms, and level of limitation. Pl.’s Mot. (dkt 14) at 5-11. 17 Medical Evidence from Treating Provider 18 Plaintiff had one treating provider – Ethan Schram, M.D. Although Dr. Schram had been 19 Plaintiff’s oncologist since April 15, 2013 (AR at 557), the first patient-visit records submitted to 20 the ALJ are dated June 1, 2016, (id. at 361-67). Dr. Schram noted that Plaintiff was diagnosed 21 with myelofibrosis in February 2013, and she had iron overload from frequent blood transfusions 22 which required chelation therapy and a prescription for Jakafi. Id. at 361. Plaintiff had a history of 23 depression, hyperlipidemia, and vitamin B12 deficiency. Id. at 362. Dr. Schram also noted that 24 Plaintiff had “more arthritis since starting Jakafi,” “brui[s]ing more than before,” and a “history of 25 depression and now on Effexor.” Id. Dr. Schram reviewed Plaintiff’s lab tests performed on May 26 23, 2016. Id. at 364. Based on his exam of Plaintiff, Dr. Schram made the following impressions: 27 1 primary myelofibrosis; pancytopenia secondary to myelofibrosis (symptomatic anemia); 2 macrocytosis; history of depression; alcohol abuse – in remission episodically; symptomatic 3 splenomegaly – now resolved on Jakafi; gout – stable; and iron overload. Id. Dr. Schram stated 4 that “[c]omplications of her tranfusional (sic) overload include arthropathy, hepatic and endocrine 5 dysfunction,” and thus recommended screening for thyroid function. Id. Dr. Schram recommended 6 that Plaintiff continue with medications to control symptoms associated with her blood 7 transfusions. Id. at 365-66. 8 Dr. Ethan Schram also completed a malignant neoplastic disease medical report on June 9 14, 2018. Id. at 557-61. He wrote that Plaintiff had the following signs or symptoms due to her 10 impairments: chronic pain, chronic fatigue, and fibrosis. Id. at 557. Plaintiff exhibited severe 11 chronic pain and paresthesia as well as constant edema in both hands, knees, feet, and neck. Id. He 12 noted that Plaintiff would be unable to perform or be exposed to routine, repetitive tasks at 13 consistent pace; fast-paced tasks (e.g. production line); and exposure to work hazards (e.g. heights 14 or moving machinery). Id. at 558. Plaintiff’s medications cause drowsiness and sedation. Id. Her 15 impairments could be expected to last at least 12 months. Id. Dr. Schram reported that Plaintiff 16 could walk 1-2 city blocks without rest or severe pain as well as sit and stand for up to 20 minutes 17 at one time. Id. Plaintiff could sit, stand, or walk for approximately 2 hours total in a 8-hour 18 workday. Id. at 559. Plaintiff’s symptoms would require her to take up to 8, 10-minute 19 unscheduled breaks to rest throughout an average 8-hour workday due to her pain, paresthesia, 20 chronic fatigue, and the adverse effects of medication. Id. Dr. Schram advised that, due to 21 Plaintiff’s edema and pain/paresthesia, her legs should be elevated 20-30% of a typical workday. 22 Id. Plaintiff could frequently lift less than 10 pounds and occasionally lift 10 pounds. Id. at 560. 23 Plaintiff’s upper extremities were significantly limited with reaching, handling, and fingering due 24 to pain, paresthesia, and swelling; she could use her hands, fingers, and arms up to 10% of an 8- 25 hour workday. Id. Dr. Schram stated Plaintiff would likely be absent from work due to the 26 impairments more than four days per month. Id. He added that Plaintiff “has chronic bone marrow 27 failure due to myelofibrosis. This leads to chronic transfusions, iron overload, and arthritis as well 1 Medical Reports of Examining & Non-Examining Consultants 2 On May 31, 2017, Dr. Amita Hedge M.D., a non-examining agency consultant, completed 3 a medical source statement. Id. at 46-48. Dr. Hedge reviewed Plaintiff’s records from consultative 4 examiners and treating providers and found Plaintiff’s statements regarding symptoms to be 5 partially consistent except for “level of severity and functioal (sic) limits.” Id. at 46. Plaintiff had 6 the following exertional limits: 20 pounds for occasional lifting/carrying; 10 pounds for frequent 7 lifting/carrying; 6 hours of standing/walking in a 8-hour workday; 6 hours of sitting in a 8-hour 8 workday; and unlimited pushing/pulling. Id. at 47. She reported that Plaintiff could occasionally 9 climb ladders, ropes, and scaffolds. Id. Plaintiff’s physical limitations were due to myelofibrosis 10 with anemia. Id. at 48. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Molina v. Astrue
674 F.3d 1104 (Ninth Circuit, 2012)
United States v. Raymond Elmore
108 F.3d 23 (Third Circuit, 1997)
Lingenfelter v. Astrue
504 F.3d 1028 (Ninth Circuit, 2007)
Vasquez v. Astrue
572 F.3d 586 (Ninth Circuit, 2009)
Jasim Ghanim v. Carolyn W. Colvin
763 F.3d 1154 (Ninth Circuit, 2014)
Biestek v. Berryhill
587 U.S. 97 (Supreme Court, 2019)
Reddick v. Chater
157 F.3d 715 (Ninth Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Gerhard v. Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gerhard-v-saul-cand-2020.